BNTX

Biontech Stock Analysis

AI Rating

Fair
  • Quality8/10
  • Growth 2/10
  • Value 1/10
Biontech sales and earnings growth
BNTX Growth
Fair
  • Revenue Y/Y 4.32%
  • EPS Y/Y -69.68%
  • FCF Y/Y 467.78%
Biontech gross and profit margin trends
BNTX Profitability
Neutral
  • Gross margin 77.60%
  • EPS margin -39.60%
  • ROIC 5Y 19.15%
Biontech net debt vs free cash flow
BNTX Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -14.0

Biontech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗